{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:57:03Z","timestamp":1790737023997,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"DOI":"10.1007\/s12664-026-02077-2","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:45:36Z","timestamp":1790736336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond bowel wall thickness: Is the international bowel ultrasound segmental activity score ready for prime time in Crohn\u2019s disease?"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7090-9004","authenticated-orcid":false,"given":"Partha","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayal Vizhi","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2077_CR1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: An update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160:1570\u201383. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.031.","journal-title":"Gastroenterology."},{"key":"2077_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaf106","author":"T Kucharzik","year":"2025","unstructured":"Kucharzik T, Taylor S, Allocca M, et al. ECCO-ESGAR-ESP-IBUS guideline on diagnostics and monitoring of patients with inflammatory bowel disease: Part 1. J Crohns Colitis. 2025;19:jjaf106.\u00a0https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaf106.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"2077_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12664-020-01019-w","volume":"39","author":"P Kakkadasam Ramaswamy","year":"2020","unstructured":"Kakkadasam Ramaswamy P, Vizhi NK, Yelsangikar A, Krishnamurthy AN, Bhat V, Bhat N. Utility of bowel ultrasound in assessing disease activity in Crohn\u2019s disease. Indian J Gastroenterol. 2020;39:495\u2013502. https:\/\/doi.org\/10.1007\/s12664-020-01019-w.","journal-title":"Indian Journal of Gastroenterology."},{"issue":"9","key":"2077_CR4","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/gutjnl-2019-319451","volume":"69","author":"C Maaser","year":"2020","unstructured":"Maaser C, Petersen F, Helwig U, et al. Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study. Gut. 2020;69:1629\u201336. https:\/\/doi.org\/10.1136\/gutjnl-2019-319451.","journal-title":"Gut"},{"key":"2077_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/ecco-jcc\/jjaa216","volume":"15","author":"KL Novak","year":"2021","unstructured":"Novak KL, Nylund K, Maaser C, et al. Expert consensus on optimal acquisition and development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A reliability and inter-rater variability study on intestinal ultrasonography in Crohn\u2019s disease. J Crohns Colitis. 2021;15:609\u201316. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa216.","journal-title":"J Crohns Colitis."},{"key":"2077_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/apt.18155","volume":"60","author":"P Pal","year":"2024","unstructured":"Pal P, Mateen MA, Pooja K, et al. Leveraging existing mid-end ultrasound machine for point-of-care intestinal ultrasound in low-resource settings: Prospective, real-world impact on clinical decision-making. Aliment Pharmacol Ther. 2024;60:633\u201347. https:\/\/doi.org\/10.1111\/apt.18155.","journal-title":"Aliment Pharmacol Ther."},{"issue":"1","key":"2077_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12664-023-01468-z","volume":"43","author":"KV Nagarajan","year":"2024","unstructured":"Nagarajan KV, Bhat N. Intestinal ultrasound in inflammatory bowel disease: New kid on the block. Indian J Gastroenterol. 2024;43:160\u201371. https:\/\/doi.org\/10.1007\/s12664-023-01468-z.","journal-title":"Indian J Gastroenterol"},{"key":"2077_CR8","doi-asserted-by":"publisher","unstructured":"Kaur A, Singh A, Bhardwaj A, et al. Diagnostic accuracy of the International Bowel Ultrasound Segmental Activity Score for assessing disease activity in Crohn\u2019s disease. Indian J Gastroenterol. 2026. https:\/\/doi.org\/10.1007\/s12664-026-02041-0.","DOI":"10.1007\/s12664-026-02041-0"},{"key":"2077_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaf170","author":"M Allocca","year":"2025","unstructured":"Allocca M, Jairath V, Sands BE, et al. International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials. J Crohns Colitis. 2025;19:jjaf170. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaf170.","journal-title":"J Crohns Colitis"},{"issue":"10114","key":"2077_CR10","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1016\/s0140-6736(17)32641-7","volume":"390","author":"JF Colombel","year":"2017","unstructured":"Colombel JF, Panaccione R, Bossuyt P, et al. Effect of tight control management on Crohn\u2019s disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet. 2017;390:2779\u201389. https:\/\/doi.org\/10.1016\/s0140-6736(17)32641-7.","journal-title":"Lancet"},{"key":"2077_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2026.103856","volume":"94","author":"P Pal","year":"2026","unstructured":"Pal P, Mateen MA, Naaz SM, et al. High-end intestinal ultrasound versus mid-end systems benchmarked against tandem ileocolonoscopy in inflammatory bowel disease (HUMID): a paired prospective, validating confirmatory study. EClinicalMedicine. 2026;94: 103856. https:\/\/doi.org\/10.1016\/j.eclinm.2026.103856.","journal-title":"EClinicalMedicine."},{"key":"2077_CR12","doi-asserted-by":"publisher","unstructured":"Qin J, Ma L, Zhou MY, et al. Determining the accuracy and interobserver agreement of 4 ultrasound scores in Crohn\u2019s disease assessment: Correlations with endoscopy. Clin Transl Gastroenterol. 2025;16:e00812. https:\/\/doi.org\/10.14309\/ctg.0000000000000812.","DOI":"10.14309\/ctg.0000000000000812"},{"issue":"10","key":"2077_CR13","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/ibd\/izad251","volume":"30","author":"Z Huang","year":"2024","unstructured":"Huang Z, Cheng W, Chao K, et al. Baseline and postinduction intestinal ultrasound findings predict long-term transmural and mucosal healing in patients with Crohn\u2019s disease. Inflamm Bowel Dis. 2024;30:1767\u201375. https:\/\/doi.org\/10.1093\/ibd\/izad251.","journal-title":"Inflamm Bowel Dis"},{"key":"2077_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaf223","author":"C Bezzio","year":"2026","unstructured":"Bezzio C, Bertin L, Saibeni S, et al. Learning curve in intestinal ultrasound: advancing from basic skills to advanced competencies-insights from the IUS IG-IBD Master program.\u00a0J Crohns Colitis. 2026;20(5):jjaf223. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaf223.","journal-title":"J Crohns Colitis"},{"key":"2077_CR15","doi-asserted-by":"publisher","unstructured":"Kucharzik T, Wilkens R, D\u2019agostino MA, et al. Early ultrasound response and progressive transmural remission after treatment with ustekinumab in Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2023;21:153\u2013163.e12.\u00a0\u00a0https:\/\/doi.org\/10.1016\/j.cgh.2022.05.055.","DOI":"10.1016\/j.cgh.2022.05.055"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-026-02077-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-026-02077-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-026-02077-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:45:40Z","timestamp":1790736340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-026-02077-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":15,"alternative-id":["2077"],"URL":"https:\/\/doi.org\/10.1007\/s12664-026-02077-2","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"30 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This article is an invited editorial and does not involve human participants, patient data or animal experiments.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Partha Pal received consultancy fee\/speaker honorarium from Johnson and Johnson, Takeda Pharmaceutical Company, Cipla Ltd, Sun Pharma, Zydus Biosciences and Dr Reddy Labs. Kayal Vizhi Nagarajan received speaker honorarium\/consultancy fee from Johnson and Johnson, Takeda Pharmaceutical Company, Sun Pharma, and Lupin Pharma.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members,\u00a0the Indian Society of Gastroenterology or the printer\/publishers are responsible for the results\/findings and content of this article.","order":5,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}